Anaplastic Lymphoma Kinase with Crizotinib

3d Illustration of Anaplastic Lymphoma Kinase with Crizotinib. ALK plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. Crizotinib (trade name Xalkori) is an anti-cancer drug that acts as an ALK inhibitor, approved for treatment of some non-small cell lung carcinoma

Restrictions Only for Ireland and United Kingdom

3-dimensional Cancer Chemical Chemistry Dimensional Genes Lymphoma Mutation Three-dimensional

Features In These Collections

> Contributors > PHR